[HTML] Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in Japanese patients with …
[HTML] Once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide is non‐inferior to once‐daily liraglutide and superior to placebo in Japanese patients with …
J Miyagawa, M Odawara, T Takamura… - Diabetes, Obesity …, 2015 - Wiley Online Library
Aims To examine the efficacy and safety of once-weekly dulaglutide monotherapy (0.75 mg)
compared with placebo and once-daily liraglutide (0.9 mg) in Japanese patients with type 2
diabetes. Methods This was a phase III, 52-week (26-week primary endpoint), randomized …
compared with placebo and once-daily liraglutide (0.9 mg) in Japanese patients with type 2
diabetes. Methods This was a phase III, 52-week (26-week primary endpoint), randomized …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Jason Lee
jason@pepmic.com
Pepmic Co., Ltdjason@pepmic.com
www.pepmic.com
评论
发表评论